Cite
HARVARD Citation
Linder, M. et al. (2018). EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling. EMBO molecular medicine. 10 (11), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Linder, M. et al. (2018). EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling. EMBO molecular medicine. 10 (11), p. n/a. [Online].